GlassScriptPhysician profile
Nitesh Sood
NPI 1124299755
$667,807.13
in general payments reported to CMS, 2019-2025
18 companies · $165K in 2025
The $165K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104K · 2020: $44K · 2021: $65K · 2022: $109K · 2023: $101K · 2024: $79K · 2025: $165K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $251K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Travel and Lodging: $37K · Food and Beverage: $8,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $250,540.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,521.00 |
| Travel and Lodging | $36,919.34 |
| Food and Beverage | $8,338.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $472,593.35 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| E.R. Squibb & Sons, L.L.C. | $59,197.91 | 2019-2025 | Eliquis, Camzyos |
| Medtronic, INC. | $58,166.37 | 2023-2025 | Affera Mapping System, Pulseselect, Arctic Front Advance |
| Pfizer INC. | $29,990.71 | 2019-2024 | |
| Cardiologs Technologies | $29,750.00 | 2021 | |
| Abbott Laboratories | $10,410.17 | 2019-2025 | Ensite, Ensite Precision, Aveir |
| Janssen Scientific Affairs, LLC | $3,600.00 | 2023 | Xarelto |
| Boston Scientific Corporation | $2,438.30 | 2019-2024 | |
| Medtronic Vascular, INC. | $693.27 | 2019-2020 | |
| Biotronik INC. | $297.96 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $158.19 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $132.70 | 2019-2022 | |
| Hemosonics LLC | $130.61 | 2022 | |
| Edwards Lifesciences Corporation | $129.32 | 2019 | |
| Arthrex, INC. | $39.92 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.93 | 2023 | Lifevest |
| Cardiva Medical, INC. | $23.57 | 2022 | |
| Cordis US Corp. | $19.85 | 2024 | Mynx Venous Vcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitesh Sood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.